A novel microencapsulation method for probiotics using polysaccharides and proteins enhances pH and thermal resistance, ensuring probiotic viability in beverages and intestinal release. Suitable for improved probiotic formulations in functional foods.
Microencapsulation of probiotics using a combination of polysaccharides and proteins offers a groundbreaking method to enhance the stability and viability of probiotics. This innovative approach involves encapsulating probiotics in a matrix of weak acids (polysaccharides) and weak bases (proteins or protein hydrolysates) to provide superior protection against pH fluctuations and thermal stress. This technique is particularly beneficial for maintaining probiotic stability in acidic environments, such as beverages, and ensuring their effective release in the intestines.
Currently at Technology Readiness Level 4, this method has shown promising results in early-stage testing, especially with soil beneficial organisms. Plans are in place to validate the approach with selected probiotic strains through microencapsulation trials and stability testing, paving the way for further development and commercial application.
Fraunhofer is a large, multi-site applied research organization based in Germany, operating a nationwide network of institutes and research units with a strong industry-facing mission. Its contract-research model aligns work to real manufacturing and deployment needs, with pilot lines, test labs, and demonstration facilities for validation and scale-up. Many institutes are integrated with nearby universities and regional industry clusters, enabling joint appointments, shared infrastructure, and fast talent pipelines. Research is supported by competitive European programs alongside German federal and state funding, complemented by extensive contract revenue from private-sector collaborations. A dedicated technology transfer function manages IP, licensing, and startup formation.